Sector: MedicalASTRAZENECA PLC (NYSE: AZN)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 186 |
Technical : | 230 |
Performance : | 237 |
Overall: | 266 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 188 |
Technical : | 241 |
Performance : | 251 |
Overall: | 276 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 189 |
Technical : | 235 |
Performance : | 260 |
Overall: | 274 |
Number of Stocks: | 305 |
Headlines
- EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
Nov 06, 2009 12:01 AM | AZN, EPCT, JNJ, LLY
- Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018
Nov 05, 2009 08:03 AM | AZN, LLY, PFE
- MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results
Nov 05, 2009 07:02 AM | AZN, MAPP
- Cubist Pharmaceuticals to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Nov 03, 2009 03:13 PM | AZN, CBST
- Neuroendocrine Tumours
Nov 03, 2009 12:22 PM | AMGN, AZN, NVS, SNY, TU
- CommonHealth's EvoLogue Wins Gold at the MM&M Awards
Nov 03, 2009 07:01 AM | AZN, WPPGY
- Quintiles Announces Clinical Pharmacology Alliance with AstraZeneca
Nov 02, 2009 09:25 AM | AZN
- Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability 50 Index
Nov 02, 2009 07:03 AM | A, ABX, AXA, AZN, BBL, BHP
- 30 to 40 % of mental illnesses in UAE are schizophrenia-related
Oct 31, 2009 11:23 AM | AZN
- Windhover Expands Its List of Top Projects to Watch
Oct 30, 2009 01:13 PM | AZN, BIIB, BMY, BVF, ENL, GENZ
- Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years
Nov 06, 2009 07:51 AM | AZN, GSK, TC, TRGT
- AstraZeneca Q3 Net Income Up
Oct 30, 2009 06:52 AM | AZN
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- Drug makers, CVS slammed for promos
Oct 18, 2009 05:47 PM | AZN, CVS, LLY, MRK
- Business Highlights
Oct 16, 2009 06:51 PM | AMZN, AZN, BAC, GE, GOOG, WMT
- Dampier Defends Woodford Income Strategy
Oct 15, 2009 05:56 AM | AZN
- FUND FOCUS: Down but Not Out
Oct 15, 2009 05:56 AM | AZN
- ANALYSIS: Liontrust's New Contrarian Process
Oct 12, 2009 05:51 AM | AZN
- Daily Mail, London, Market Report Column
Sep 02, 2009 10:54 AM | AZ, AZN, BMY, SNY
- Evening Standard, London, Market Report Column
Sep 01, 2009 05:56 PM | AZ, AZN, BMY, C, GS, GSK
- Phase Forward Reports Third Quarter 2009 Results
Oct 29, 2009 04:56 PM | AGN, AZN, CVD, LLY, PFWD, PG
- Howard Dean to Speak at the 2009 Mid-Atlantic Bio Conference
Oct 29, 2009 12:53 PM | AZN, HGSI
- AstraZeneca: Third Quarter and Nine Months Results 2009
Oct 29, 2009 09:57 AM | AZN, FRX, NKTR
- POZEN Reports Third Quarter 2009 Results
Oct 28, 2009 07:52 AM | AZN, POZN
- Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
Oct 22, 2009 07:51 AM | AZN, BMY, GILD, LLY
- Merck Announces Third-Quarter 2009 Financial Results
Oct 22, 2009 07:51 AM | AZN, MRK
- Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%
Oct 15, 2009 04:51 PM | ALNY, AZN, CBST
- Targacept Announces Pricing of Common Stock Offering
Oct 08, 2009 10:53 AM | AZN, TRGT
- Targacept Announces Common Stock Offering
Oct 08, 2009 09:51 AM | AZN, TRGT
- Troux Secures $10 Million to Extend Growth in New Geographies and Channels
Oct 08, 2009 06:50 AM | AZN
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AZN
|
Compare to S&P
|
| YTD |
9.46 %
|
-4.59 %
|
| 4 Weeks |
2.91 %
|
1.82 %
|
| 12 Weeks |
-3.42 %
|
-5.82 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -10.98 %
|
|
EPS Growth in Last Year: 22.69 %
|
|
Sales Growth in Last Quarter: 3.04 %
|
|
Sales Growth in Last Quarter: 5.47 %
|
|
